Smaller, shallow brain folds in the posteromedial cortex show greater thinning with age and Alzheimer’s disease, and their ...

A new tool developed by researchers can estimate how fast someone is aging by analyzing a single MRI brain scan, predicting ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Cognito Therapeutics has reached its enrolment goal for the HOPE Study investigating the Spectris AD system for Alzheimer's disease (AD).

Alzheimer's may represent a form of brain-specific diabetes, with insulin resistance linking it to type 2 diabetes and ...

Dementia prevalence in India is rising, with experts emphasizing comprehensive evaluations, reversible causes, and global therapy advances.

Cognito Therapeutics Completes Enrollment in HOPE Pivotal Study of Spectris™ AD Therapy for the Treatment of Patients with Alzheimer’s Disease ...

A recent study published in Nature Neuroscience provides evidence that lemborexant, a medication used to treat insomnia, can reduce brain damage linked to Alzheimer’s disease in a mouse model. The ...

New indication added for selection of patients for amyloid-directed therapiesQuantitative image analysis addedPrevious limitations of use removed Amyloid, a naturally occurring protein, can accumulate ...

Hiding deep inside the body, a dangerous type of fat wraps itself around vital organs such as the kidneys, liver and heart — ...